ChronoScale Holdings (CHRN) Restructuring Costs (2012 - 2020)
ChronoScale Holdings' (CHRN) quarterly Restructuring Costs came in at $244000.0 in Q2 2020, up 4166.67% quarter-over-quarter from -$6000.0 in Q4 2017.
Powered by 
Analysis
ChronoScale Holdings (CHRN) Restructuring Costs (2012 - 2020) Analysis & Trends
ChronoScale Holdings (CHRN) has reported Restructuring Costs for 4 consecutive years, with $244000.0 the latest figure, recorded in Q2 2020.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $244000.0 in Q2 2020; TTM through Jun 2021 was $244000.0, a 0.0% change from a year earlier, with the FY2020 full-year figure at $244000.0, changed N/A from the prior year.
- Restructuring Costs was $244000.0 for Q2 2020 at ChronoScale Holdings, up from -$6000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $665000.0 in Q2 2017 and troughed at -$6000.0 in Q4 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | ChronoScale Holdings | 2.52 Bn | 2.51 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 244,000.00 |
| Dec 31, 2017 | -6,000.00 |
| Jun 30, 2017 | 665,000.00 |
| Dec 31, 2013 | 151.00 |
| Sep 30, 2013 | 60.00 |
| Jun 30, 2013 | 31.00 |
| Dec 31, 2012 | 315.00 |
| Sep 30, 2012 | 89.00 |
| Jun 30, 2012 | 37.00 |